BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nantasanti S, Spee B, Kruitwagen HS, Chen C, Geijsen N, Oosterhoff LA, van Wolferen ME, Pelaez N, Fieten H, Wubbolts RW, Grinwis GC, Chan J, Huch M, Vries RRG, Clevers H, de Bruin A, Rothuizen J, Penning LC, Schotanus BA. Disease Modeling and Gene Therapy of Copper Storage Disease in Canine Hepatic Organoids. Stem Cell Reports. 2015;5:895-907. [PMID: 26455412 DOI: 10.1016/j.stemcr.2015.09.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Kramer N, Pratscher B, Meneses AMC, Tschulenk W, Walter I, Swoboda A, Kruitwagen HS, Schneeberger K, Penning LC, Spee B, Kieslinger M, Brandt S, Burgener IA. Generation of Differentiating and Long-Living Intestinal Organoids Reflecting the Cellular Diversity of Canine Intestine. Cells 2020;9:E822. [PMID: 32231153 DOI: 10.3390/cells9040822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Oliveira AG, Fiorotto R. Novel approaches to liver disease diagnosis and modeling. Transl Gastroenterol Hepatol 2021;6:19. [PMID: 33824923 DOI: 10.21037/tgh-20-109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Van den Bossche L, Schoonenberg VAC, Burgener IA, Penning LC, Schrall IM, Kruitwagen HS, van Wolferen ME, Grinwis GCM, Kummeling A, Rothuizen J, van Velzen JF, Stathonikos N, Molenaar MR, Helms BJ, Brouwers JFHM, Spee B, van Steenbeek FG. Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts. PLoS One 2017;12:e0186491. [PMID: 29049355 DOI: 10.1371/journal.pone.0186491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Meneses AMC, Schneeberger K, Kruitwagen HS, Penning LC, van Steenbeek FG, Burgener IA, Spee B. Intestinal Organoids-Current and Future Applications. Vet Sci 2016;3:E31. [PMID: 29056739 DOI: 10.3390/vetsci3040031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 Willemse J, Lieshout R, van der Laan LJ, Verstegen MM. From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix. Best Practice & Research Clinical Gastroenterology 2017;31:151-9. [DOI: 10.1016/j.bpg.2017.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
6 Clevers H. Modeling Development and Disease with Organoids. Cell. 2016;165:1586-1597. [PMID: 27315476 DOI: 10.1016/j.cell.2016.05.082] [Cited by in Crossref: 990] [Cited by in F6Publishing: 958] [Article Influence: 198.0] [Reference Citation Analysis]
7 Lancaster MA, Huch M. Disease modelling in human organoids. Dis Model Mech 2019;12:dmm039347. [PMID: 31383635 DOI: 10.1242/dmm.039347] [Cited by in Crossref: 124] [Cited by in F6Publishing: 110] [Article Influence: 41.3] [Reference Citation Analysis]
8 Kruitwagen HS, Oosterhoff LA, van Wolferen ME, Chen C, Nantasanti Assawarachan S, Schneeberger K, Kummeling A, van Straten G, Akkerdaas IC, Vinke CR, van Steenbeek FG, van Bruggen LWL, Wolfswinkel J, Grinwis GCM, Fuchs SA, Gehart H, Geijsen N, Vries RG, Clevers H, Rothuizen J, Schotanus BA, Penning LC, Spee B. Long-Term Survival of Transplanted Autologous Canine Liver Organoids in a COMMD1-Deficient Dog Model of Metabolic Liver Disease. Cells 2020;9:E410. [PMID: 32053895 DOI: 10.3390/cells9020410] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Sang Y, Miller LC, Nelli RK, Giménez-Lirola LG. Harness Organoid Models for Virological Studies in Animals: A Cross-Species Perspective. Front Microbiol 2021;12:725074. [PMID: 34603253 DOI: 10.3389/fmicb.2021.725074] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Augustyniak J, Bertero A, Coccini T, Baderna D, Buzanska L, Caloni F. Organoids are promising tools for species-specific in vitro toxicological studies. J Appl Toxicol 2019;39:1610-22. [PMID: 31168795 DOI: 10.1002/jat.3815] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
11 Corbee RJ, Penning LC. COMMD1 Exemplifies the Power of Inbred Dogs to Dissect Genetic Causes of Rare Copper-Related Disorders. Animals (Basel) 2021;11:601. [PMID: 33668783 DOI: 10.3390/ani11030601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Francipane MG, Lagasse E. Towards Organs on Demand: Breakthroughs and Challenges in Models of Organogenesis. Curr Pathobiol Rep 2016;4:77-85. [PMID: 28979828 DOI: 10.1007/s40139-016-0111-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 Kruitwagen HS, Fieten H, Penning LC. Towards Bioengineered Liver Stem Cell Transplantation Studies in a Preclinical Dog Model for Inherited Copper Toxicosis. Bioengineering (Basel) 2019;6:E88. [PMID: 31557851 DOI: 10.3390/bioengineering6040088] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Baptista PM, Penning LC. Transplantable Liver Organoids, Too Many Cell Types to Choose: a Need for Scientific Self-Organization. Curr Transpl Rep 2020;7:18-23. [DOI: 10.1007/s40472-020-00266-2] [Reference Citation Analysis]
15 . ABSTRACTS (BY NUMBER): These are the abstracts as submitted through the website. Last minute changes, title and presenting changes are not always reflected in this file.. Tissue Engineering Part A 2022;28:S-1-S-654. [DOI: 10.1089/ten.tea.2022.29025.abstracts] [Reference Citation Analysis]
16 Zhu X, Zhang B, He Y, Bao J. Liver Organoids: Formation Strategies and Biomedical Applications. Tissue Eng Regen Med 2021;18:573-85. [PMID: 34132985 DOI: 10.1007/s13770-021-00357-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Nantasanti S, de Bruin A, Rothuizen J, Penning LC, Schotanus BA. Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals. Stem Cells Transl Med. 2016;5:325-330. [PMID: 26798060 DOI: 10.5966/sctm.2015-0152] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
18 Runft S, Färber I, Krüger J, Krüger N, Armando F, Rocha C, Pöhlmann S, Burigk L, Leitzen E, Ciurkiewicz M, Braun A, Schneider D, Baumgärtner L, Freisleben B, Baumgärtner W. Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review. Vet Pathol 2022;:3009858211073678. [PMID: 35130766 DOI: 10.1177/03009858211073678] [Reference Citation Analysis]
19 Lu H, Zhang J, Chen YE, Garcia-Barrio MT. Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases. Cardiovasc Drugs Ther 2021;35:637-54. [PMID: 33856594 DOI: 10.1007/s10557-021-07175-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chen C, Pla-Palacín I, Baptista PM, Shang P, Oosterhoff LA, van Wolferen ME, Penning LC, Geijsen N, Spee B. Hepatocyte-like cells generated by direct reprogramming from murine somatic cells can repopulate decellularized livers. Biotechnol Bioeng 2018;115:2807-16. [PMID: 29959867 DOI: 10.1002/bit.26784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kawasaki M, Goyama T, Tachibana Y, Nagao I, Ambrosini YM. Farm and Companion Animal Organoid Models in Translational Research: A Powerful Tool to Bridge the Gap Between Mice and Humans. Front Med Technol 2022;4:895379. [DOI: 10.3389/fmedt.2022.895379] [Reference Citation Analysis]
22 Kar SK, Wells JM, Ellen ED, Te Pas MFW, Madsen O, Groenen MAM, Woelders H. Organoids: a promising new in vitro platform in livestock and veterinary research. Vet Res 2021;52:43. [PMID: 33691792 DOI: 10.1186/s13567-021-00904-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
23 Lee SW, Jung DJ, Jeong GS. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models. Tissue Eng Regen Med 2020;17:731-45. [PMID: 32207030 DOI: 10.1007/s13770-020-00245-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
24 Baliou S, Adamaki M, Kyriakopoulos AM, Spandidos DA, Panayiotidis M, Christodoulou I, Zoumpourlis V. CRISPR therapeutic tools for complex genetic disorders and cancer (Review). Int J Oncol 2018;53:443-68. [PMID: 29901119 DOI: 10.3892/ijo.2018.4434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
25 Nuciforo S, Heim MH. Organoids to model liver disease. JHEP Rep 2021;3:100198. [PMID: 33241206 DOI: 10.1016/j.jhepr.2020.100198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
26 Prior N, Inacio P, Huch M. Liver organoids: from basic research to therapeutic applications. Gut 2019;68:2228-37. [PMID: 31300517 DOI: 10.1136/gutjnl-2019-319256] [Cited by in Crossref: 123] [Cited by in F6Publishing: 102] [Article Influence: 41.0] [Reference Citation Analysis]
27 Nguyen R, Da Won Bae S, Qiao L, George J. Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer research. Cancer Lett 2021;508:13-7. [PMID: 33771683 DOI: 10.1016/j.canlet.2021.03.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Kim S, Cho A, Min S, Kim S, Cho S. Organoids for Advanced Therapeutics and Disease Models. Adv Therap 2019;2:1800087. [DOI: 10.1002/adtp.201800087] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
29 Kruitwagen HS, Penning LC. Preclinical models of Wilson's disease, why dogs are catchy alternatives. Ann Transl Med 2019;7:S71. [PMID: 31179308 DOI: 10.21037/atm.2019.02.06] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
30 Chen C, Jochems PGM, Salz L, Schneeberger K, Penning LC, van de Graaf SFJ, Beuers U, Clevers H, Geijsen N, Masereeuw R, Spee B. Bioengineered bile ducts recapitulate key cholangiocyte functions. Biofabrication 2018;10:034103. [PMID: 29848792 DOI: 10.1088/1758-5090/aac8fd] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
31 Wu LJ, Chen ZY, Wang Y, Zhao JG, Xie XZ, Chen G. Organoids of liver diseases: From bench to bedside. World J Gastroenterol 2019; 25(16): 1913-1927 [PMID: 31086460 DOI: 10.3748/wjg.v25.i16.1913] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
32 Pierson H, Yang H, Lutsenko S. Copper Transport and Disease: What Can We Learn from Organoids? Annu Rev Nutr 2019;39:75-94. [PMID: 31150593 DOI: 10.1146/annurev-nutr-082018-124242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
33 Timmermans-Sprang EPM, Mestemaker HM, Steenlage RR, Mol JA. Dasatinib inhibition of cSRC prevents the migration and metastasis of canine mammary cancer cells with enhanced Wnt and HER signalling. Vet Comp Oncol 2019;17:413-26. [PMID: 31069942 DOI: 10.1111/vco.12490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mochel JP, Jergens AE, Kingsbury D, Kim HJ, Martín MG, Allenspach K. Intestinal Stem Cells to Advance Drug Development, Precision, and Regenerative Medicine: A Paradigm Shift in Translational Research. AAPS J 2017;20:17. [PMID: 29234895 DOI: 10.1208/s12248-017-0178-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
35 Chen C, Soto-Gutierrez A, Baptista PM, Spee B. Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells. Gastroenterology 2018;154:1258-72. [PMID: 29428334 DOI: 10.1053/j.gastro.2018.01.066] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
36 Wu X, Chien H, van Wolferen ME, Kruitwagen HS, Oosterhoff LA, Penning LC. Reduced FXR Target Gene Expression in Copper-Laden Livers of COMMD1-Deficient Dogs. Vet Sci 2019;6:E78. [PMID: 31574998 DOI: 10.3390/vetsci6040078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wu X, Leegwater PA, Fieten H. Canine Models for Copper Homeostasis Disorders. Int J Mol Sci 2016;17:196. [PMID: 26861285 DOI: 10.3390/ijms17020196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
38 Weiskirchen R, Penning LC. COMMD1, a multi-potent intracellular protein involved in copper homeostasis, protein trafficking, inflammation, and cancer. J Trace Elem Med Biol 2021;65:126712. [PMID: 33482423 DOI: 10.1016/j.jtemb.2021.126712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Hindley CJ, Cordero-Espinoza L, Huch M. Organoids from adult liver and pancreas: Stem cell biology and biomedical utility. Dev Biol 2016;420:251-61. [PMID: 27364469 DOI: 10.1016/j.ydbio.2016.06.039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
40 Nguyen R, Bae SDW, Zhou G, Read SA, Ahlenstiel G, George J, Qiao L. Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers. Biochim Biophys Acta Rev Cancer 2020;1873:188350. [PMID: 32007597 DOI: 10.1016/j.bbcan.2020.188350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Kruitwagen HS, Oosterhoff LA, Vernooij IGWH, Schrall IM, van Wolferen ME, Bannink F, Roesch C, van Uden L, Molenaar MR, Helms JB, Grinwis GCM, Verstegen MMA, van der Laan LJW, Huch M, Geijsen N, Vries RG, Clevers H, Rothuizen J, Schotanus BA, Penning LC, Spee B. Long-Term Adult Feline Liver Organoid Cultures for Disease Modeling of Hepatic Steatosis. Stem Cell Reports. 2017;8:822-830. [PMID: 28344000 DOI: 10.1016/j.stemcr.2017.02.015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
42 Sánchez-Romero N, Sainz-Arnal P, Pla-Palacín I, Dachary PR, Almeida H, Pastor C, Soto DR, Rodriguez MC, Arbizu EO, Martinez LB, Serrano-Aulló T, Baptista PM. The role of extracellular matrix on liver stem cell fate: A dynamic relationship in health and disease. Differentiation 2019;106:49-56. [PMID: 30878881 DOI: 10.1016/j.diff.2019.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
43 Schneeberger K, Spee B, Costa P, Sachs N, Clevers H, Malda J. Converging biofabrication and organoid technologies: the next frontier in hepatic and intestinal tissue engineering? Biofabrication 2017;9:013001. [PMID: 28211365 DOI: 10.1088/1758-5090/aa6121] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
44 Tavares MR, de Castro RVG, Pieri NCG, Cruz NRN, Martins DS, Ambrósio CE, Garcia JM, Camplesi AC, Bressan FF, Toniollo GH. Identification of hepatic progenitor cells in the canine fetal liver. Res Vet Sci 2020;133:239-45. [PMID: 33032111 DOI: 10.1016/j.rvsc.2020.09.012] [Reference Citation Analysis]
45 Günther C, Brevini T, Sampaziotis F, Neurath MF. What gastroenterologists and hepatologists should know about organoids in 2019. Dig Liver Dis 2019;51:753-60. [PMID: 30948332 DOI: 10.1016/j.dld.2019.02.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
46 Cotovio JP, Fernandes TG. Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications. Bioengineering (Basel) 2020;7:E36. [PMID: 32283585 DOI: 10.3390/bioengineering7020036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
47 Molenaar MR, Penning LC, Helms JB. Playing Jekyll and Hyde-The Dual Role of Lipids in Fatty Liver Disease. Cells 2020;9:E2244. [PMID: 33036257 DOI: 10.3390/cells9102244] [Reference Citation Analysis]
48 Caiazza C, Parisi S, Caiazzo M. Liver Organoids: Updates on Disease Modeling and Biomedical Applications. Biology (Basel) 2021;10:835. [PMID: 34571712 DOI: 10.3390/biology10090835] [Reference Citation Analysis]
49 Shiota J, Samuelson LC, Razumilava N. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet? Hepatology 2021;74:2251-63. [PMID: 33638203 DOI: 10.1002/hep.31772] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]